Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Capital Expenditures: 2010-2024

Historic Capital Expenditures for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to $2.4 million.

  • Cryo Cell International's Capital Expenditures fell 7911.32% to $38788.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $225302.0, marking a year-over-year decrease of 9210.32%. This contributed to the annual value of $2.4 million for FY2024, which is 6485.28% down from last year.
  • Latest data reveals that Cryo Cell International reported Capital Expenditures of $2.4 million as of FY2024, which was down 6485.28% from $6.8 million recorded in FY2023.
  • Cryo Cell International's Capital Expenditures' 5-year high stood at $12.2 million during FY2022, with a 5-year trough of $99962.0 in FY2020.
  • Over the past 5 years, Cryo Cell International's median Capital Expenditures value was $2.4 million (recorded in 2024), while the average stood at $4.7 million.
  • In the last 5 years, Cryo Cell International's Capital Expenditures plummeted by 8490.67% in 2020 and then skyrocketed by 173469.42% in 2021.
  • Annual analysis of 5 years shows Cryo Cell International's Capital Expenditures stood at $99962.0 in 2020, then soared by 1734.69% to $1.8 million in 2021, then soared by 563.49% to $12.2 million in 2022, then crashed by 43.8% to $6.8 million in 2023, then tumbled by 64.85% to $2.4 million in 2024.
  • Its last three reported values are $2.4 million in FY2024, $6.8 million for FY2023, and $12.2 million during FY2022.